Dario doller (19 Ergebnisse)

Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

Zustand: New.

Zustand: New. In English.

Zustand: New.

Buch. Zustand: Neu. Trends in CNS Drug Discovery | Dario Doller (u. a.) | Buch | Trends in Drug Discovery | 480 S. | Englisch | 2026 | Wiley-VCH GmbH | EAN 9783527352807 | Verantwortliche Person für die EU: Wiley-VCH GmbH, Boschstr. 12, 69469 Weinheim, product-safety[at]wiley[dot]com | Anbieter: preigu. …

hardcover. Zustand: New.

Zustand: Used.

Zustand: Hervorragend. Zustand: Hervorragend | Seiten: 480 | Sprache: Englisch | Produktart: Bücher | Provides insights into the drug discovery innovations that are shaping future CNS therapies In the vast field of neuroscience, drug discovery targeting the central nervous system (CNS) presents both extraordinary opportunities and complex challenges. Disorders such as Alzheimer's disease, schizophrenia, and epilepsy affect millions worldwide, demanding innovative therapeutic strategies. Yet understanding brain processes and overcoming the blood-brain barrier continue to pose significant hurdles for researchers and developers alike. Trends in CNS Drug Discovery offers a comprehensive overview of the methodologies, successes, and challenges shaping this critical area of pharmaceutical research. Covering a wide range of key areas, from current therapeutic paradigms to emerging technologies, this state-of-the-art volume brings together expertise from leading scientists and drug developers who address the role of cannabinoids and psychedelics in advancing CNS therapeutics, discuss emerging modalities such as protein degraders and allosteric modulators, examine funding strategies and academic-industrial collaborations, highlight advancements in brain-penetrating cancer treatments and other high-impact areas, and more. - Explores cutting-edge methodologies, including biomarkers, animal models, and brain imaging for CNS drug discovery - Reviews innovative therapies such as combination drugs and prodrugs for improved treatment outcomes - Analyzes challenges in targeting diseases including Alzheimer's and schizophrenia with novel therapeutic strategies - Includes real-world case studies demonstrating achievements and lessons in CNS drug development A critical reference for academic researchers and industry professionals in medicinal chemistry, pharmaceutical research, and neurobiology, Trends in CNS Drug Discovery is also an ideal resource for graduate-level courses in neuroscience or pharmaceutical sciences.…

Buch. Zustand: Neu. Neuware - Trends and challenges in one of the largest areas of contemporary drug development - presented by industry professionals with a track record of discovering new drugs and treatments.

Buch. Zustand: Neu. Neuware -Provides insights into the drug discovery innovations that are shaping future CNS therapiesWiley-VCH GmbH, Boschstraße 12, 69469 Weinheim 480 pp. Englisch.

Hardcover. Zustand: Brand New. gld edition. 565 pages. 9.20x6.20x1.20 inches. In Stock.

Zustand: New. In English.

Gebunden. Zustand: New. This book, written by the leaders in this young research area, describes the latest developments in allosterism for drug discovery.InhaltsverzeichnisrnrnModulation of Biological Targets: Why Use Allosteric Ligands? Identifying and Quantifyi.

Buch. Zustand: Neu. Neuware -Provides insights into the drug discovery innovations that are shaping future CNS therapies In the vast field of neuroscience, drug discovery targeting the central nervous system (CNS) presents both extraordinary opportunities and complex challenges. Disorders such as Alzheimer's disease, schizophrenia, and epilepsy affect millions worldwide, demanding innovative therapeutic strategies. Yet understanding brain processes and overcoming the blood-brain barrier continue to pose significant hurdles for researchers and developers alike. Trends in CNS Drug Discovery offers a comprehensive overview of the methodologies, successes, and challenges shaping this critical area of pharmaceutical research. Covering a wide range of key areas, from current therapeutic paradigms to emerging technologies, this state-of-the-art volume brings together expertise from leading scientists and drug developers who address the role of cannabinoids and psychedelics in advancing CNS therapeutics, discuss emerging modalities such as protein degraders and allosteric modulators, examine funding strategies and academic-industrial collaborations, highlight advancements in brain-penetrating cancer treatments and other high-impact areas, and more. - Explores cutting-edge methodologies, including biomarkers, animal models, and brain imaging for CNS drug discovery - Reviews innovative therapies such as combination drugs and prodrugs for improved treatment outcomes - Analyzes challenges in targeting diseases including Alzheimer's and schizophrenia with novel therapeutic strategies - Includes real-world case studies demonstrating achievements and lessons in CNS drug development A critical reference for academic researchers and industry professionals in medicinal chemistry, pharmaceutical research, and neurobiology, Trends in CNS Drug Discovery is also an ideal resource for graduate-level courses in neuroscience or pharmaceutical sciences. 480 pp. Englisch.…

Hardcover. Zustand: gut. 2025. Trends in CNS Drug Discovery In deutscher Sprache. pages.

Hardcover. Zustand: Brand New. gld edition. 565 pages. 9.20x6.20x1.20 inches. In Stock.

Buch. Zustand: Neu. Neuware - Although the concept of allosterism has been known for over half a century, its application in drug discovery has exploded in recent years. The emergence of novel technologies that enable molecular-level ligand-receptor interactions to be studied in unprecedented detail has driven this trend. This book describes the latest research using small molecules as chemical probes and drug candidates that interact allosterically with proteins of relevance to life sciences and human disease.…